These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29600542)

  • 1. A new 2% testosterone gel formulation: a comparison with currently available topical preparations.
    Arver S; Stief C; de la Rosette J; Jones TH; Neijber A; Carrara D
    Andrology; 2018 May; 6(3):396-407. PubMed ID: 29600542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new testosterone gel (fortesta) for hypogonadism.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of testosterone gel in the treatment of male hypogonadism.
    Lakshman KM; Basaria S
    Clin Interv Aging; 2009; 4():397-412. PubMed ID: 19966909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function.
    McNicholas TA; Dean JD; Mulder H; Carnegie C; Jones NA
    BJU Int; 2003 Jan; 91(1):69-74. PubMed ID: 12614254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Testosterone Topical Solution in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel.
    Burns PR; Kim ED; Ruff DD; Seftel AD
    Am J Mens Health; 2018 May; 12(3):524-530. PubMed ID: 26438471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testim 1% testosterone gel for the treatment of male hypogonadism.
    Bouloux P
    Clin Ther; 2005 Mar; 27(3):286-98. PubMed ID: 15878382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel.
    Marbury T; Hamill E; Bachand R; Sebree T; Smith T
    Biopharm Drug Dispos; 2003 Apr; 24(3):115-20. PubMed ID: 12673669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of Testim gel.
    McNicholas T; Ong T
    Expert Opin Pharmacother; 2006 Mar; 7(4):477-84. PubMed ID: 16503819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
    Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
    Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone topical solution (Axiron) for hypogonadism.
    Med Lett Drugs Ther; 2011 Jul; 53(1368):54-5. PubMed ID: 21738108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISM.
    Cunningham G; Belkoff L; Brock G; Efros M; Gittelman M; Carrara D; Neijber A; Ando M; Mitchel J
    Endocr Pract; 2017 May; 23(5):557-565. PubMed ID: 28225313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New testosterone 2% gel using Ferring Advanced Skin Technology (FAST), for the treatment of testosterone deficiency in men, with a novel applicator.
    Kirby M; Kalhan A; Hackett G
    Expert Rev Endocrinol Metab; 2020 Jul; 15(4):217-226. PubMed ID: 32552045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal delivery of testosterone.
    Hadgraft J; Lane ME
    Eur J Pharm Biopharm; 2015 May; 92():42-8. PubMed ID: 25709060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption of testosterone gel 1% (Testim) from three different application sites.
    Guay AT; Smith TM; Offutt LA
    J Sex Med; 2009 Sep; 6(9):2601-10. PubMed ID: 19549089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone treatment to mimic hormone physiology in androgen replacement therapy. A view on testosterone gel and other preparations available.
    Fabbri A; Giannetta E; Lenzi A; Isidori AM
    Expert Opin Biol Ther; 2007 Jul; 7(7):1093-106. PubMed ID: 17665996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New modalities of transdermal testosterone replacement.
    Basaria S; Dobs AS
    Treat Endocrinol; 2003; 2(1):1-9. PubMed ID: 15871550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone-topical fortigel - cellegy: fortigel, tostrex.
    BioDrugs; 2003; 17(4):299-300. PubMed ID: 12899649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men.
    Dinsmore WW; Wyllie MG
    BJU Int; 2012 Jul; 110(2):162-9. PubMed ID: 22288877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of the 2% formulation of testosterone topical solution applied to the axillae in androgen-deficient men.
    Wang C; Ilani N; Arver S; McLachlan RI; Soulis T; Watkinson A
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):836-43. PubMed ID: 21689131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.